LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial
14 juin 2024 11h00 HE | Lixte Biotechnology Holdings, Inc.
Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE...
GRI Bio Announces Reverse Stock Split
14 juin 2024 08h05 HE | GRI Bio, Inc.
GRI’s common stock is expected to begin trading on a post-split adjusted basis on June 18, 2024      LA JOLLA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the...
Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System
06 juin 2024 08h30 HE | Lixte Biotechnology Holdings, Inc.
LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune System by Disrupting the Process of RNA Splicing PASADENA, CA, June 06, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology...
Global Neutropenia Market Competitive Analysis and Forecast Report to 2028, Featuring BeyondSpring Pharmaceuticals, Coherus Biosciences, Myelo Therapeutics and Spectrum Pharmaceuticals
15 mars 2024 05h14 HE | Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Global Neutropenia Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
27 févr. 2024 15h52 HE | BioAegis Therapeutics
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
Food Allergy Market to Witness Remarkable Growth, Key Insights, and Global Outlook Revealed in New 2031 Forecast Report
06 févr. 2024 10h06 HE | Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Food Allergy Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to...
Psoriasis Global Market Report 2024: Market to Surge to $39.17 Billion by 2028, Middle East Poised for Rapid Growth - Long-term Forecasts to 2033
26 janv. 2024 03h17 HE | Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The psoriasis market is undergoing significant...
US Food Allergen Testing Market Outlook to 2028 - New York Commands Attention in the Eastern Region with Innovative Allergens Detection Technology
14 déc. 2023 11h08 HE | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "US Food Allergen Testing Market Outlook to 2028" report has been added to ResearchAndMarkets.com's offering. With the increasing prevalence of food...
Mikra to Introduce Innovative Immune Support Gummy
14 déc. 2023 07h00 HE | Lifeist Wellness Inc.
Mikra introduces PROTECT, a new natural immune support product based on Aronia berries and key vitamins
RationalStat Logo 1.png
Immune System Supplements Market to be Worth US$ 38.9 billion by 2030, Registering a Strong CAGR of 10.5% - Says a Market Report by RationalStat
01 nov. 2023 02h12 HE | Rationalstat LLC
Wilmington, Delaware, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Global Immune System Supplements Market is valued at US$ 19.3 billion in 2023 and is expected to grow at a significant CAGR of over 10.5% over...